Commentary: Congress has just weeks to help children with rare diseases
A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...
Iranian Immigrant Becomes Billionaire As Her Biotech Firm’s Stock Soars
Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...
GEN5d
Double Impact: Interest Rates and Prospects For Biotech Growth
The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...
First-ever 'China Week' takes aim at America’s dependence on Beijing
The China fight is on. Last week, the House of Representatives stepped up to the Herculean task of passing 25 bills targeting ...
It was 'tough on China' week in Congress, one of the few issues both parties agree on
Lawmakers took up more than two dozen mostly Republican-led measures aimed at countering Beijing’s technological, political ...
The 5:2 diet gave me motor neurone disease, scientist claims
Dr Vivienne Cox believes that carbohydrates and sweet treats were fuelling her body and keeping amyotrophic lateral sclerosis ...
The White House launched a politically potent high-tech program this year. There’s a reason you haven’t heard of it.
The national, bipartisan Tech Hubs program could have been a campaign winner. Instead, it’s underfunded and barely present on ...
Medpage Today on MSN3d
Experts Debate Whether IRA Provisions Stifle Pharma Innovation at Senate Hearing
One witness at Tuesday's hearing, retired RN and patient Judy Aiken of Portland, Maine, testified that the IRA was crucial in ...
How to (not) fund the future
Progress always has a price tag, but today’s bleeding-edge technologies are unusually capital-intensive — energy-thirsty AI ...
MT Newswires on MSN5d
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
European equities traded in the US as American depositary receipts started the week higher late Monday morning, rising 0.31% to 1,446.05 on the S&P Europe Select ADR Index. From continental Europe, ...